A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer. (Q40545094)
Jump to navigation
Jump to search
scientific article published on 10 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer. |
scientific article published on 10 September 2015 |
Statements
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer (English)
Thomas Powles
Omar Din
Thomas Geldart
Ekaterini Boleti
Andrew Stockdale
Angus Robinson
Imtiaz Ahmed
Akhila Wimalasingham
Wendy Burke
Shah-Jalal Sarker
11 September 2015